Hansoh Pharmaceutical Group Company Limited (3692.HK)
HKD 18.5
(0.11%)
HKD 18.5
(0.11%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 6.23 Billion CNY | 6.79% |
| 2022 | 5.83 Billion CNY | -2.15% |
| 2021 | 5.96 Billion CNY | 20.5% |
| 2020 | 4.95 Billion CNY | -3.37% |
| 2019 | 5.12 Billion CNY | 5.71% |
| 2018 | 4.84 Billion CNY | 26.23% |
| 2017 | 3.83 Billion CNY | 17.98% |
| 2016 | 3.25 Billion CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 3.27 Billion CNY | 0.0% |
| 2023 FY | 6.23 Billion CNY | 6.79% |
| 2023 Q2 | 2.86 Billion CNY | 0.0% |
| 2023 Q4 | 3.4 Billion CNY | 0.0% |
| 2022 Q4 | 3.18 Billion CNY | 0.0% |
| 2022 Q2 | 2.65 Billion CNY | 0.0% |
| 2022 FY | 5.83 Billion CNY | -2.15% |
| 2021 FY | 5.96 Billion CNY | 20.5% |
| 2021 Q2 | 2.54 Billion CNY | 0.0% |
| 2021 Q4 | 3.41 Billion CNY | 0.0% |
| 2020 FY | 4.95 Billion CNY | -3.37% |
| 2020 Q4 | 2.74 Billion CNY | 0.0% |
| 2020 Q2 | 2.2 Billion CNY | 0.0% |
| 2019 Q2 | 2.71 Billion CNY | 0.0% |
| 2019 FY | 5.12 Billion CNY | 5.71% |
| 2019 Q4 | 2.4 Billion CNY | 0.0% |
| 2018 FY | 4.84 Billion CNY | 26.23% |
| 2018 Q4 | 2.57 Billion CNY | 0.0% |
| 2018 Q2 | 2.25 Billion CNY | 0.0% |
| 2017 Q4 | 1.21 Billion CNY | 0.0% |
| 2017 Q1 | 959.87 Million CNY | 0.0% |
| 2017 Q2 | 959.87 Million CNY | 0.0% |
| 2017 FY | 3.83 Billion CNY | 17.98% |
| 2016 Q4 | 959.87 Million CNY | 0.0% |
| 2016 Q1 | 813.58 Million CNY | 0.0% |
| 2016 FY | 3.25 Billion CNY | 0.0% |
| 2016 Q2 | 813.58 Million CNY | 0.0% |
| 2015 Q4 | 813.58 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 24.42 Million HKD | -25422.527% |
| Grand Pharmaceutical Group Limited | 3.86 Billion HKD | -61.465% |
| Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | -17446.154% |
| Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | -1661.244% |
| Qianhai Health Holdings Limited | 17.1 Million HKD | -36349.667% |
| Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | -954.773% |
| Essex Bio-Technology Limited | 1.22 Billion HKD | -407.226% |
| Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | -1138.149% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -2777.557% |
| SSY Group Limited | 1.98 Billion HKD | -214.712% |
| JBM (Healthcare) Limited | 163.87 Million HKD | -3703.865% |
| Jacobson Pharma Corporation Limited | 287.34 Million HKD | -2069.356% |
| China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 78.764% |